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Abstract
Background: Insulin is an anorexigenic hormone that contributes to the termination of food intake in the postprandial
state. An alteration in insulin action in the brain, named ‘‘cerebral insulin resistance’’, is responsible for overeating and the
development of obesity.
Methodology/Principal Findings: To analyze the direct effect of insulin on food-related neuronal activity we tested 10 lean
and 10 obese subjects. We conducted a magnetencephalography study during a visual working memory task in both the
basal state and after applying insulin or placebo spray intranasally to bypass the blood brain barrier. Food and non-food
pictures were presented and subjects had to determine whether or not two consecutive pictures belonged to the same
category. Intranasal insulin displayed no effect on blood glucose, insulin or C-peptide concentrations in the periphery;
however, it led to an increase in the components of evoked fields related to identification and categorization of pictures (at
around 170 ms post stimuli in the visual ventral stream) in lean subjects when food pictures were presented. In contrast,
insulin did not modulate food-related brain activity in obese subjects.
Conclusions/Significance: We demonstrated that intranasal insulin increases the cerebral processing of food pictures in
lean whereas this was absent in obese subjects. This study further substantiates the presence of a ‘‘cerebral insulin
resistance’’ in obese subjects and might be relevant in the pathogenesis of obesity.
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Introduction
Obesity with its growing incidence and prevalence and its costs
for the health system is currently a research focus in different
scientific disciplines ranging from internal medicine to neurosci-
ence. However, the underlying mechanisms that lead to overeating
and obesity are not yet fully understood.
Human eating behavior is controlled by homeostatic and
hedonic mechanisms [1,2]. Whereas homeostatic mechanisms are
based on signals from the periphery to the brain [3,4], the hedonic
aspects are based on emotional factors which are triggered by
visual, olfactory and gustatory signals [5,6].
In the homeostatic regulation of food intake, the modulation is
basically achieved by nutritional and hormonal factors. One of the
most prominent hormons in the postprandial state is insulin, which
is secreted from beta-cells after a meal. Insulin receptors are widely
expressed throughout the brain, especially in the hypothalamus,
the olfactory bulb, the cerebellum and the cortex [7–9]. Various
animal studies demonstrated that insulin in the brain controls and
suppresses food intake [10–12]. Furthermore, knock-out models
for insulin receptors in the brain displayed obesity and insulin
resistance [13]. In humans, we demonstrated in a magnetoence-
phalographic (MEG) study that the insulin-mediated increase in
spontaneous brain activity and auditory evoked fields during a
hyperinsulinemic-euglycemic clamp is reduced in obese subjects
[14]. During visual stimulation with a checkerboard, Benedict
et al. [15] and Seaquist et al. [16] showed no effect of insulin on
visual evoked potentials. However, Benedict et al. reported an
effect of insulin on the later evoked component (P300) in a
recognition memory task and they further demonstrated an
improvement in memory by insulin [17].
Most of the studies in humans to date were performed with
systemic insulin application and alterations at the blood-brain
barrier in obese subjects were not taken into account [18].
Therefore, in the present study, insulin was administered intrana-
sally to enter the brain via the olfactory nerve and bulb and to raise
insulin concentrations in the cerebrospinal fluid without relevant
absorption to the systemic blood circulation [19–21]. In this respect,
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the brain without affecting glucose metabolism in the periphery. We
recently used this study protocol in a functional magnetic resonance
imaging study (fMRI) to investigate the effect of insulin on neuronal
activity and detected a reduction in the blood oxygen level
dependent response (BOLD) after intranasal administration of
insulin compared to placebo in the fusiform gyrus [22].
There have been few studies to date dealing with the neuronal
processes related to food pictures. One group by Porubska et al.
showed in a fMRI study that the BOLD response was increased by
food pictures compared to non-food pictures [23]. In addition,
studies performed with EEG and MEG have demonstrated a very
detailed insight into the time dynamics of processing food-related
pictures in the human brain [23–26]. In our previous study with
MEG [24] we were able to show the temporal sequence of
neuronal activation during visual processing of food pictures,
whereas in the current study we have focused on the effect of
insulin in this network.
Methods
Objectives
We hypothesized that insulin modulates food specific activation
in the brain dependent on body weight, and therefore evaluated
evoked magnetic fields in lean and obese subjects before and after
intranasal insulin administration.
Participants
Subjects were recruited via email advertisement. We originally
included 26 healthy subjects in the study. Six subjects had to be
excluded based on the following criteria: one subject due to a severe
migraine occured during the study, another subject did not show up
for the second recording session, two further subjects were excluded
based on artifacts during recordings and lastly two more subjects
were excluded based on preset performance criteria during the
memory task of ,75% (pressing at random could not be excluded).
Therefore, 10 lean (f/m=7/3, age 25.761.5 years, BMI
20.960.4 kg/m
2) and 10 obese subjects (f/m=7/3, age 26.761.8
years,BMI28.860.6 kg/m
2) tookpartinourinvestigation.None of
the subjects suffered from any severe disease or eating disorder.
Volunteers withdiabetes mellitus or with a familyhistoryof diabetes
were excluded at screening, as well as those undergoing treatment
for a chronic disease or taking any form of medication.
Furthermore, a routine blood analysis was conducted to detect
any unknown metabolic or organic diseases. All subjects were
normal sighted or had corrected-to-normal vision.
Study protocol
The placebo and insulin study was conducted on two days in a
single-blind randomized cross over study. After 12 hour overnight
fast, the experiment was started at 8: 00 am with basal blood
sampling and basal MEG measurements. This was followed by
intranasal insulin or placebo administration. When insulin levels in
the cerebrospinal fluid reached their highest concentrations after
30 minutes [19], the second MEG measurement was performed.
Blood was taken every 30 minutes from the beginning of the
experiment to determine plasma glucose, insulin and C-peptide
levels. The study lasted approximately two hours.
Nasal spray administration
Nasal spray was administered via spray pumps as previously
described [27]. Subjects received either insulin (U100, Insulin
Actrapid; Novo Nordisk, Mainz, Germany) or placebo (HOE 31
dilution buffer for H-Insulin; Aventis Pharma, Bad Soden,
Germany). Each dosage consisted of 10 IU in a total volume of
0,1 ml and the subjects were administered a totel of 16 doses
(160 IU). To ensure optimal absorption, the total dosage was
applied in 3 minutes. Both, the insulin and the placebo spray
contained cresole so that the subjects could not differentiate
between the two sprays.
Analytical measurements
Plasma glucose was determined using the glucose-oxidase
method (YSI, Yellow Springs Instruments, Yellow Springs, CO,
USA). Plasma insulin and C-peptide levels were determined with
commercial chemiluminescence assays for ADVIA Centaur
(Siemens Medical Solutions, Fernwald, Germany).
Stimulus material
The subject had to perform a one-back visual memory task
while inside the MEG. During the task, 64 food and 64 non-food
pictures matched for color, size and complexity were presented in
a randomized order. The subject was asked to determine whether
the current picture belonged to the same object category as the
previous one (one-back task). If the second picture belonged to the
same object category as the first one, the subject pushed the button
with their right index finger (‘‘same’’ category -e.g. food – food:
FF, and non-food – non-food: NN). If the picture did not belong to
the same object category, the subject pushed the button with their
right middle finger (‘‘not-same’’ category -e.g. food – non-food: FN
and non-food – food: NF) (for a more detailed description of the
protocol see Stingl et al. [24]). Subjects were excluded from further
analysis if the percentage of correct answers was below 75%.
Stimulus presentation was controlled with PresentationH (Neuro-
behavioral Systems, Inc., Albany, CA.).
MEG data acquisition
MEG signals were recorded using a 275 sensor whole head
system (VSM, Medtech, Vancouver, Canada). The continuous
recording was filtered off line with a 40 Hz low-pass and a 1 Hz
high pass filter and separated into trials of 2100 ms length (from
2100 ms to 2000 ms) according to the previous stimulus (condi-
tions FF, FN, NF, NN). The baseline of each trial was defined
according to the pre-stimulus interval of 100 ms. All of the trials
with eye movement artifacts (detected by threshold criteria) were
excluded from further analysis. The trials were averaged for each
condition and each subject, and then again averaged for all subjects
for every experimental condition. According to our recent study,
two different evoked potential components (M1: 100–140 ms,
generated in primary visual areas and M2: 140–190 ms, generated
in higher visual areas, especially the fusifrom gyrus) showed stronger
responses after the presentation of food pictures compared to non-
food pictures [24]. The response for the two time windows was
quantified by the mean of the root mean square values (RMS) of all
channels of the evoked potentials for the specific window and by
latency of maximum amplitude of RMS for that component.
Furthermore, we showed that there is no difference between
conditions for satiated subjects when the previous stimulus was food
or non-food [24]. This result was reproduced in the current study
and based on this, we combined the conditions FF and NF to the
condition ‘‘food’’ and NN and FN to the condition ‘‘non-food’’ for
the investigation of the effect of insulin.
Ethics
The protocol was approved by the local Ethics Committee in
Tu ¨bingen, Germany and informed written consent was obtained
from all participants.
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All data are given as unadjusted mean 6 SEM. Non-normally
distributed parameters were log transformed to approximate normal
distribution prior to statistical analysis. MANOVA analysis was used
to test for significant differences in metabolic parameters between
insulin and placebo experiments with the software package JMP 7.0
(SAS Institute, Cary, NC). Results with p#0.05 were considered
statistically significant.
For the analysis of the behavioral and basal measurement, we
used a three-way repeated analysis of variance (ANOVA) with two
within factors ‘‘preceding stimulus’’ (levels: food and non-food)
and ‘‘current stimulus’’ (levels: food and non-food) and one
between factor weight (levels: obese and lean).
The analysis on the insulin effect was preformed for ‘‘food’’ and
‘‘non-food’’ condition. As a measure of insulin action, we calculated
the difference for M1 and M2 after insulin application and basal
measurement adjusted for the placebo measurement [(insulin 2 –
insulin 1) – (placebo 2 – placebo 1)]. A two tailed t-test was
performed separately for each condition (food, non-food) and each
group (lean, obese) for both periods to determine the effect of
insulin.ForstatisticalanalysisSPSS14.0(SPSSInc.,Illinois;U.S.A.)
and Matlab 2007 (The MathWorks, Inc., Natick, USA) were used.
The source activation was calculated for the difference between
insulin application and basal measurement adjusted for the placebo
measurement [(insulin 2 – insulin 1) – (placebo 2 – placebo 1)] for
each subject. For source reconstruction, an empirical Bayesian
approach [28–30] was used inthe time window 100–350 ms (SPM8
http://www.fil.ion.ucl.ac.uk/spm). A standard cortical surface
template was transformed to match the fiducials of the MEG data
[29].Inallcases,the sensorlocationswere registeredtosource space
and the gain matrix was computed using a single shell head model.
Thedatacovariancewas used toestimatetheMultiple SparsePriors
maximizing the free-energy approximation to the model-evidence
(using automaticrelevance determination)[31]. For the second level
analysis, we applied a spatial filter of 12 mm. The solutions from
individual subjects were grouped and we used a t-test to calculate
the statistical parametric map for calculation of areas which showed
specific insulin effects. We report all regional activations above the
initial significance threshold p,0.05 (FWR corrected).
Results
Metabolic parameters
Obese subjects had slightly higher HbA1c as compared to lean
subjects (5.560.1% vs. 5.460.1 in lean). Furthermore, fasting
plasma glucose, insulin and C-peptide concentrations were higher
in the obese group as compared to the lean group (glucose:
p,0.001, insulin: p,=0.01, C-peptide: p,=0.001, Table 1).
There was no statistical difference in blood glucose levels between
the placebo and insulin condition in both the lean and the obese
group. After insulin application, insulin levels remained unaltered
and C-peptide concentrations did not differ between the insulin
and placebo conditions (Table 1).
Behavioral results for basal measurements
Behavioraldatafromtwobasalmeasurementswerecombined for
each subject. There was a significant main effect for the factors
previousandcurrent. Theaccuracyoftheresponsewashigherif the
previous picture was food-related (F(1,18)=37.46, p,0.001). For
the current factor, we also found the accuracy to be higher for food
pictures compared to non-food pictures (F(1,18)=14.28,
p=0.0013). For reaction time (RT), the main significant effect
was for the factors previous and current. The RT was significantly
decreased in conditions where food was the preceding factor
(F(1,18)=136.47, p,0.001) and for conditions where food was the
current factor (F(1,18)=9.28, p=0.0069) in comparison with non-
food. The interaction between preceding and current factor was
only statistically significant for accuracy (F=36.8, p,0.001). There
was no significant main effect for the factor weight or interaction
effect between weight and any other factor for accuracy or RT.
MEG data for basal measurements
The wave form of the evoked potentials showed two peaks (M1
and M2) within the first 200 ms both in lean and in obese subjects.
The main factor current was significant for the RMS values. A
significant increase in RMS was observed at both peaks for food
compared to non-food in lean and obese subject (M1 -
F(1,18)=36.05, p,0.001 and M2 F(1,18)=29.75, p,0.001)
(Table 2, Fig. 1). None of the other factors or interactions was
significant. The RMS values for the M1 and M2 component and
the peak amplitude analysis between the lean and obese group
were not statistically significant (see Table S1 and Table S2). In
addition, no significant main effect or interaction was found for the
latency of the M1 and M2 components (Table 2).
MEG results after intranasal insulin application
Neither reaction time nor accuracy of the response to the
pictures showed a significant effect related to the insulin
application.
Table 1. Metabolic parameters during MEG experiment (Insulin or placebo spray was given at time=0 min).
Placebo Insulin Placebo Insulin Placebo Insulin Placebo Insulin Placebo Insulin Placebo Insulin
Lean subjects Obese subjects Lean subjects Obese subjects Lean subjects Obese subjects
Time (minutes) Glucose (mmol/l) Insulin (pmol/l) C-Peptide (pmol/l)
230 4.760.1 4.660.1 5.260.1 5.160.1 3965.6 3463.9 59610.3 68611.9 360636 336634 520653 609652
04 . 7 60.1 4.860.1 5.360.2 5.360.2 3365.5 3365.1 61611.8 62611.4 379653 336639 554669 584662
30 4.460.1 4.660.1 5.060.1 5.060.1 3364.8 4165.8 70615.9 88615.5 345636 314638 535666 595682
60 4.460.1 4.660.1 5.160.2 5.160.1 3266.8 3464.8 65612.1 6669.1 372651 289629 555667 544668
p-value (time*
insulin/placebo)
0.31 0.76 0.42 0.23 0.19 0.07
All data are given as mean 6 SEM.
Statistical significance between insulin and placebo condition was performed using MANOVA analysis, univariate test and interaction effect.
The p-value time*insulin/placebo shows differences in the curves over time of insulin and placebo.
doi:10.1371/journal.pone.0019482.t001
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insulin. However, insulin led to an increase in the M2 component
for food pictures in lean subjects (p=0.005) but not in obese
subjects (Fig. 2). The insulin application did not induce significant
changes in neuronal activity for the non-food pictures in lean or
obese subjects for both components (Fig. 2).
The source analysis revealed significant insulin-mediated
changes in a neural network involving visual, temporal and
parietal areas with the strongest change in activity in the inferior
occipital region (Fig. 3).
Discussion
Previous studies suggested that the increase in cortical activity
during a hyperinsulinemic-euglycemic clamp is prominent in lean
subjects whereas this effect was suppressed in obese subjects [14]
which indicates insulin resistance in the brain. As it has been
demonstrated in various mouse models, insulin resistance in the
brain is one factor in the pathogenesis of overeating and obesity
[13,18,32–34]. We therefore evaluated the processing of food
pictures by using the MEG technique and its modulation by
insulin in lean and obese subjects. Food- and non-food pictures
were matched for visual complexity and to account for alterations
in the periphery and at the level of the blood brain barrier, insulin
was administered intranasally to enter the brain via the olfactory
nerve and bulb without affecting metabolic parameters in the
periphery [19,20].
In our study, the increase of the M1 component for food
compared to non-food stimuli during the basal measurement
replicates the finding for lean, satiated subjects [24]. Furthermore,
an equivalent increase was shown in lean and obese subjects after
an overnight fast in the current study. The reduction of RT and
increase of accuracy, as shown in our previous study [24], is
related to the memorization of the preceding food picture. The
behavioral measures and the M1 and M2 component of the
evoked fields were not statistically different in lean and obese
subjects.
Besides the fact that M1 and M2 components are not different
at the basal level between lean and obese subjects, we found that
food-related brain activity in the visual area was increased in lean
subjects following intranasal insulin application, while obese
subjects showed no effect and therefore displayed cerebral insulin
resistance.
An insulin-mediated increase in cerebral activity in lean subjects
was previously described in a study from our group during a
hyperinsulinemic-euglycemic clamp with systemic insulin admin-
istration [14]. Another support for insulin action in the brain was
found in a functional magnetic resonance imaging study with
intranasal administration of insulin on a visual recognition task
using food and non-food pictures [22]. After insulin administra-
tion, there was significantly reduced activity in the presence of
food pictures in the right and left fusiform gyrus, the right
hippocampus, the right temporal superior cortex and the right
frontal middle cortex that might be linked to the termination of
food intake.
As insulin did not modulate brain action in lean subjects when
non-food pictures were presented [22], we conclude that insulin
Figure 1. Basal evoked potentials in lean and obese subjects. Time traces of evoked magnetic fields quantified by RMS for food and non-food
conditions during the baseline measurement for lean (left) and obese subjects (right). The time point zero indicates the time when the ‘‘current’’
stimulus was shown. For lean and obese subjects, a significant difference in the M1 and M2 components were found for the factor ‘‘current’’ stimulus,
e.g. an increase in M1 and M2 for food versus non-food stimulus.
doi:10.1371/journal.pone.0019482.g001
Table 2. RMS and latency of the components M1 and M2 for
the four experimental conditions.
FF NF FN NN
RMS Lean-M1 (fT) 57646 0 635 3 635 2 63
RMS Obese-M1 (fT) 64626 4 625 7 625 5 62
RMS Lean-M2 (fT) 72637 7 636 3 626 3 62
RMS Obese-M2 (fT) 74637 7 636 0 626 0 62
Mean Latency Lean-M1 (ms) 124611 2 3 611 2 2 611 2 2 61
Mean Latency Obese-M1 (ms) 126621 2 5 621 2 4 621 2 5 62
Mean Latency Lean-M2 (ms) 170621 7 2 621 6 8 611 7 5 63
Mean Latency Obese-M2 (ms) 171611 7 0 611 7 2 621 7 1 62
All data are given as mean 6 SEM.
fT=femto Tesla, 10
215 Tesla.
doi:10.1371/journal.pone.0019482.t002
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categorization of food, which is also confirmed by results at the
source level. This might be the reason why other protocols like
checkerboard visual tasks, as used in the study from Seaquist et al.
[16], were not able to discriminate the effect of insulin on visual
evoked potentials.
Source space analysis revealed the largest significant activity
change in the inferior occipital areas including the fusiform gyrus
in lean but not in obese subjects. This indicates that during this
task, mainly perceptional brain areas are activated. In keeping
with this, lean subjects showed increased activity by food objects in
perceptional visual areas which were significantly attenuated by
two days of overfeeding [35]. In that study, it was not reported
whether there was a change in insulin sensitivity in these subjects
during this intervention; however it can be speculated that
overfeeding promotes insulin resistance in the brain to diminish
brain activity. Further studies should aim to elucidate the
connection of the perceptional effect on reward and cognitive
processing that are related to feeding behavior. Based on the work
by Figlewitz and Benoit [36] it is suggestive that insulin interacts
with feeding related reward areas especially through the midbrain
dopamine system which is altered in obese subjects [37].
We want to acknowledge some limitations of the present study.
First of all, the number of subjects investigated was rather small. As
Hallschmid et al. [20] showed that intranasal insulin reduced body
fat in men but not in women, a limitation of our study is that we
used more female than male subjects. However, females were
shown to have greater prefrontal neuronal responses to food cues
compared to males [38]. Furthermore, as demonstrated by Clegg
et al. [39], insulin action in the brain is influenced by gonadal
hormones. In our study, the time of measurement was not
concerted with the menstrual cycle, but in a recent study [40] it
was demonstrated that mainly activity in the corticolimbic system
is affected by the menstrual cycle during visual food stimulation. In
Figure 2. Evoked potentials before and after insulin application. Time traces of evoked magnetic fields quantified by RMS for the
measurements before (red line) and after intranasal (green line) insulin application. In the upper row, the response of lean (a) and obese (b) subjects
to food stimuli as ‘‘current’’ stimulus are shown. In the lower row, the responses to non-food-pictures are shown (c: lean, d: obese). Only for lean
subjects, a statistical significant difference between basal and insulin in the M2 component was found.
doi:10.1371/journal.pone.0019482.g002
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stimulation demonstrated mainly effects by physiological interac-
tions (satiated versus hungry) or changes in higher processing areas
[40]. Based on these studies, we assume that our results are not
affected by these factors. Secondly, it would have been an
advantage to have accurate insulin levels in the cerebrospinal fluid,
however, we were not able to add this procedure to our setting.
The dose of insulin was based on a study from Benedict et al. that
used 160 IU of intranasal insulin per day to demonstrate
significant changes in memory [17,41] and previous studies
detected elevated insulin levels in the cerebrospinal fluid with
doses as low as 40 U of insulin intranasally [19]. We chose to not
take real food as stimuli of neuronal activation as food-related
information is primarily processed by the visual system and it is
well established that food pictures differentially activate brain
regions compared to non-food pictures [42,43]. Therefore,
stimulation with food pictures is a powerful and easy to handle
tool in investigating the mechanisms of food intake.
Taken together, our data show that insulin in the brain
potentiates food-related neuronal activity in the components that
represent identification and categorization of food pictures in lean
subjects, while this was absent in obese. Whether this contributes
to overeating and the pathogenesis of obesity needs to be evaluated
in further studies.
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